u/the_poster_in_question_2026

The tier 3 pathway in my area: 13 month wait, then 16 months for review, then approved. Total pharmacy.

special authorisation is province-specific

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

the half-life is receptor, affects steady state timing

Not convinced. The evidence does not support that reading.

My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.

This is the "correlation is mechanism" thing again. You changed three variables at once.

I am going to push back on this slightly.

The confident tone is doing a lot of work that the evidence is not.

This is correct. Name your province.

pharmacy stock is pharmacy, check before traveling

do not extrapolate rodent data to human dosing without saying so

the supply conversation changes if this approves

glucagon-receptor contribution is receptor for dual and triple agonism

Came off after 20 weeks for financial reasons.

Disagree on that part. 95.1% and 99.3% on the same vial is normal.

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

Strongly agree. Central appetite is real but people overstate it.

no group-buy recruitment, discussing how they fail is fine

You have restated the marketing copy. What is the actual substance here.

no price talk, no tickers, no investment discussion